1. Canada Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
RavenQuest BioMed Inc.

RavenQuest BioMed Inc.

RVVQF
RavenQuest BioMed Inc.US flagOther OTC
0.00
USD
- -
- -
1,236.00Market Cap
2008 Y
2009 Y
2010 Y
2011 Y
2012 Y
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
TTM
Revenue per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
0.01
0.01
Basic EPS, GAAP
- -
- -
- -
- -
- -
-0.02
- -
- -
- -
-0.1
-0.33
-0.28
Free Cash Flow per Basic Share
- -
- -
-0.01
-0.01
- -
- -
- -
- -
- -
-0.08
-0.26
-0.07
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
-0.08
-0.08
-0.08
-0.06
-0.06
-0.07
-0.07
-0.08
-0.08
-0.17
-0.4
-0.39
Tangible Book Value per Share
- -
- -
0.02
0.01
0.01
-0.01
-0.01
-0.01
-0.02
0.12
0.04
0.04
Basic Weighted Avg Shares
22
22
24
28
28
29
29
29
29
32
91
116
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
2
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
-571.08
-1,366.72
-1,199.47
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
2
4
Net Income, GAAP
- -
- -
- -
- -
- -
-1
- -
- -
- -
-3
-30
-32
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
-2,938.14
-2,424.36
-2,125.41
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
3
- -
-3
LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
13
13
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
8
22
21
Return on Invested Capital (%)
- -
- -
- -
- -
-42.58
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
-6.23
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -

Capital Structure

FRC

•

in mil. unless spec.
Jan'19
Apr'19
Jul'19
ST Debt
1
1
1
LT Borrowings
13
14
13
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
113
118
124
Market Capitalization
68
72
46

Working Capital

FRC

•

in mil. unless spec.
Jan'19
Apr'19
Jul'19
Total Current Assets
3
3
3
Cash, Cash Equivalents & STI
1
1
1
Accounts Receivable, Net
- -
- -
1
Inventories
- -
- -
- -
Total Current Liabilities
6
6
6
Payables & Accruals
3
2
2
ST Debt
1
1
1
Deferred Revenue
2
2
2

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
1,827.8%
-302.25%
195.81%
Free Cash Flow
866.7%
1,690.55%
835.76%
Net Income, GAAP
398.76%
944.03%
822.98%
Sales/Revenue/Turnover
- -
- -
1,018.58%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2017
- -
- -
- -
- -
- -
2018
1
1
- -
- -
1
2019
- -
1
1
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2017
- -
- -
-0.01
- -
-0.1
2018
-0.01
-0.04
-0.03
- -
-0.33
2019
-0.03
-0.03
-0.03
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2017
- -
- -
- -
- -
- -
2018
- -
- -
- -
- -
- -
2019
- -
- -
- -
- -
- -

Company Description

APIChat
CEO
David Allen Cross
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Address
580 Hornby Street Vancouver BC Canada V6E 2K3
IPO Date
Mar 5, 2018
Website
rqbglobal.com
Similar Companies
RLS Global AB (publ) (RLS.ST)
Radient Technologies Inc. (RTI.V)
Bright Green Corporation (BGXXQ)
Aurora Cannabis Inc. (21P1.F)
Valeo Pharma Inc. (VPHIF)
Blum Holdings, Inc. (BLMH)
Business
RavenQuest BioMed Inc. (CSE:RQB, OTCQB:RVVQF) is a Canada-based diversified cannabis company focused on cannabis production, management services and consulting, and specialized research and development; it operates through segments including consulting business and cultivation and sale of medical cannabis. The company produces and sells cannabis products under the Lore Cannabis and Bloomera brand names; it provides integrated solutions such as growing and drying technologies, patient and genetic management systems, and security management solutions to companies in the cannabis industry. RavenQuest maintains licensed production facilities in Markham, Ontario, and Edmonton, Alberta, and emphasizes partnerships with Indigenous communities; it holds a research partnership with McGill University focused on cultivar recognition, plant stabilization, and yield maximization. Founded in 1987 and formerly known as Ravencrest Resources Inc. until its name change in September 2017, the company is headquartered in Vancouver, British Columbia, at 1177 West Hastings Street, Suite 2300. In recent developments, RavenQuest settled a patent infringement agreement with Roto-Gro International Limited in December 2024; the company was delisted from the Canadian Securities Exchange in May 2021 following a suspension in 2020, shifting its primary trading to OTC markets.